Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
AVBP
#2111
ArriVent BioPharma, Inc. Common Stock
22.9
7
+0.22%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.22%
Aylık değişim
-1.20%
6 aylık değişim
+19.57%
Yıllık değişim
-4.01%
Önceki kapanış
22.9
2
Open
22.9
3
Bid
Ask
Low
22.9
3
High
22.9
7
Hacim
76
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
AVBP
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
33.7 M
34.02 M
34.21 M
40.57 M
41.28 M
—
Valuation ratios
Enterprise value
508.98 M
831.9 M
582.73 M
770.42 M
648.97 M
2.83 B
Price to earnings ratio
—
-10.41
-4.92
-5.43
-4.36
-25.11
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
11.94
5.17
5.8
4.48
27.39
Price to book ratio
—
3.25
0.59
0.74
0.65
5.23
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.08
0.3
0.12
0.11
0.6
Return on equity %
0.07
0.08
0.32
0.13
0.11
0.64
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
19.28
13.14
14.34
12.74
14.9
55.12
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.49
0.51
2.01
0.75
0.85
4.12
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
8.42
2.36
5.19
6.73
7.16
21.45
Net current asset value per share
8.71
7.21
5.48
7.15
7.66
27.5
Tangible book value per share
8.26
8.19
5.97
7.14
7.28
28.58
Working capital per share
8.26
6.66
5.1
6.58
7.15
25.5
Book value per share
8.26
8.19
5.97
7.14
7.28
28.58
Haberler
Cantor Fitzgerald, ArriVent hissesi için Ağırlık Artırma notunu yineledi
ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald
Oppenheimer, ArriVent BioPharma hissesi için Outperform notunu yineledi
Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock
ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)
Cantor Fitzgerald, ArriVent BioPharma hissesini Ağırlık Üstü tavsiyesiyle takibe aldı
Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating
ArriVent, akciğer kanseri ilacı için önemli faz 3 çalışmasında ilk hastaya doz verdi
ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug
BTIG, ArriVent BioPharma’ya onkoloji potansiyeli nedeniyle Al tavsiyesi verdi
ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential